Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Eiji Takeuchi
Kensuke Kondo
Yoshio Okano
Michihiro Kunishige
Yoshihiro Kondo
Naoki Kadota
Hisanori Machida
Nobuo Hatakeyama
Keishi Naruse
Hirokazu Ogino
Hiroshi Nokihara
Tsutomu Shinohara
Yasuhiko Nishioka
机构：
[1] National Hospital Organization Kochi Hospital,Department of Clinical Investigation
[2] Tokushima University,Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences
[3] National Hospital Organization Kochi Hospital,Department of Respiratory Medicine
[4] National Hospital Organization Kochi Hospital,Department of Pathology
[5] Tokushima University,Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Early death; Early mortality factors; Immune checkpoint inhibitors; Lung cancer; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3139 / 3147
页数：8
相关论文
共 50 条
  • [1] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
    Takeuchi, Eiji
    Kondo, Kensuke
    Okano, Yoshio
    Kunishige, Michihiro
    Kondo, Yoshihiro
    Kadota, Naoki
    Machida, Hisanori
    Hatakeyama, Nobuo
    Naruse, Keishi
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3139 - 3147
  • [2] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung
    Takeuchi, Eiji
    Kondo, Kensuke
    Okano, Yoshio
    Ichihara, Seiya
    Kunishige, Michihiro
    Kadota, Naoki
    Machida, Hisanori
    Hatakeyama, Nobuo
    Naruse, Keishi
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    ANNALS OF ONCOLOGY, 2023, 34 : S1395 - S1396
  • [3] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Ziyi Xu
    Xuezhi Hao
    Ke Yang
    Qi Wang
    Jing Wang
    Lin Lin
    Fei Teng
    Junling Li
    Puyuan Xing
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3081 - 3089
  • [4] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Xu, Ziyi
    Hao, Xuezhi
    Yang, Ke
    Wang, Qi
    Wang, Jing
    Lin, Lin
    Teng, Fei
    Li, Junling
    Xing, Puyuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3081 - 3089
  • [5] Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Inoue, Masaaki
    Kusanagi, Kasumi
    Honda, Yohei
    Yoshida, Junichi
    Tanaka, Masao
    AGING MEDICINE, 2021, 4 (01) : 42 - 46
  • [6] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [7] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [8] Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
    Oya, Yuko
    Kuroda, Hiroaki
    Nakada, Takeo
    Takahashi, Yusuke
    Sakakura, Noriaki
    Hida, Toyoaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [9] 5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy
    Bjornhart, Birgitte
    Mouritzen, Mette Thune
    Kristiansen, Charlotte
    Schytte, Tine
    Wedervang, Kim
    Pohl, Mette
    Hansen, Karin Holmskov
    ACTA ONCOLOGICA, 2023, 62 (08) : 861 - 870
  • [10] Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
    Ou Yamaguchi
    Hisao Imai
    Hiroyuki Minemura
    Kensuke Suzuki
    Satoshi Wasamoto
    Yukihiro Umeda
    Takashi Osaki
    Norimitsu Kasahara
    Junji Uchino
    Tomohide Sugiyama
    Shinichi Ishihara
    Hisashi Ishii
    Ichiro Naruse
    Keita Mori
    Mie Kotake
    Kenya Kanazawa
    Koichi Minato
    Hiroshi Kagamu
    Kyoichi Kaira
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 761 - 771
12345